Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.64 |
| ▸ | PRKDC | P78527 | 5/20 | 0.49 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.44 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | CDC25C | P30307 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615935 | 1.00 | ALOX5 (0.64) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL13615905 | 1.00 | ALOX5 (0.64) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL13615865 | 0.98 | ALOX5 (0.66) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL16133258 | 0.97 | ALOX5 (0.64) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL21035456 | 0.97 | ALOX5 (0.64) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL21035455 | 0.97 | ALOX5 (0.64) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL25082024 | 0.94 | ALOX5 (0.57) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL25082020 | 0.94 | ALOX5 (0.57) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL16133246 | 0.94 | ALOX5 (0.59) | ALOX5PRKDCGGPS1PTGES2CDC25A | |
| SCHEMBL16133276 | 0.93 | ALOX5 (0.57) | ALOX5PRKDCGGPS1PTGES2CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | ALOX5 44/4885PRKDC 4236/4885GGPS1 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.